Comparison

Usnic acid European Partner

Item no. HY-N0656-20mg
Manufacturer MedChem Express
CASRN 125-46-2
Amount 20 mg
Quantity options 100 mg 10 mg 20 mg 500 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 98.03
Formula C18H16O7
Citations [1]Kim KJ, et al. Effect of Usnic Acid on Osteoclastogenic Activity. J Clin Med. 2018 Oct 12;7(10). pii: E345.
Smiles O=C(C1(C)C(OC2=C(C(C)=O)C(O)=C(C)C(O)=C12)=C3)C(C(C)=O)C3=O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 125-46-2
Available
Product Description
Usnic acid, a lichen-derived secondary metabolite, has a unique dibenzofuran skeleton. Usnic acid has excellent anticancer and antimicrobial properties. Usnic acid significantly inhibits RANKL-mediated osteoclast formation and function by reducing the transcriptional and translational expression of NFATc1[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-immunoregulation
MolecularWeight
344.32
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Infection
Solubility
DMSO : 3.33 mg/mL (ultrasonic; warming; heat to 60°C)
Target
Bacterial
Manufacturers Target
Bacterial
Manufacturers Pathway
Anti-infection
Manufacturers Product type
Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 20 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close